Digoxin is a cardiac glycoside that inhibits the sodium-potassium ATPase pump, increasing intracellular calcium and enhancing myocardial contractility. It is used clinically to manage heart failure and control ventricular rate in atrial fibrillation. Toxicity can cause arrhythmias, making careful dosing and monitoring essential.